Guardant Health, Inc. GH
154.78 USD -0.57 (-0.37%)
At closeNov 12, 2026, 8:30 AM EST
155.50 +0.72 +0.47%
Pre-market · Nov 12, 8:30 AM ET
153.41 Day range 163.39
74.55 52-week range 191.05
- YTD
- +51.54%
- 1 year
- +58.41%
GH revenue history
Revenue is income from the company’s ordinary business activities.
982,021,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 982,021,000 | 243,005,000 | 32.88% |
| FY 2024 | 2024-12-31 | 739,016,000 | 175,068,000 | 31.04% |
| FY 2023 | 2023-12-31 | 563,948,000 | 114,410,000 | 25.45% |
| FY 2022 | 2022-12-31 | 449,538,000 | 75,885,000 | 20.31% |
| FY 2021 | 2021-12-31 | 373,653,000 | 86,923,000 | 30.32% |
| FY 2020 | 2020-12-31 | 286,730,000 | 72,355,000 | 33.75% |
| FY 2019 | 2019-12-31 | 214,375,000 | 123,736,000 | 136.52% |
| FY 2018 | 2018-12-31 | 90,639,000 | 40,797,000 | 81.85% |
| FY 2017 | 2017-12-31 | 49,842,000 | 24,593,000 | 97.40% |
| FY 2016 | 2016-12-31 | 25,249,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-01T06:01:07.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.